✦ LIBER ✦

Trial watch: Success for crizotinib in ALK-driven cancer

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Trial watch: Ipilimumab success in melan

📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 164 KB

Budget Impact Of Crizotinib For Alk-Posi

✍ Rosado-Buzzo, A.; Garcia-Mollinedo, L.; Luna-Casas, G.; Mould-Quevedo, J.F.; Gut 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

Trial watch: Enzyme replacement success

✍ Crunkhorn, Sarah 📂 Article 📅 2012 🏛 Nature Publishing Group 🌐 English ⚖ 68 KB

Crizotinib administered via nasogastric

✍ Tamai, Koji; Nagata, Kazuma; Otsuka, Kyoko; Nakagawa, Atsushi; Tachikawa, Ryo; O 📂 Article 📅 2013 🏛 Elsevier 🌐 English ⚖ 381 KB

Cost-Effectiveness of EML4-ALK Fusion Te

✍ Djalalov, S.; Beca, J.; Hoch, J.S.; Krahn, M.D.; Tsao, M.S.; Cutz, J.C.; Leighl, 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

Cost-Effectiveness Of Eml4-Alk Fusion Te

✍ Djalalov, S.; Hoch, J.S.; Beca, J.; Krahn, M.; Tsao, M.S.; Cutz, J.C.; Leighl, N 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB